Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Change in Acquisitions & Divestments (2020 - 2025)

Cryo Cell International (CCEL) has disclosed Change in Acquisitions & Divestments for 7 consecutive years, with $265196.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 68.24% to $265196.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $2.8 million, a 83.86% increase, with the full-year FY2025 number at $2.8 million, up 83.86% from a year prior.
  • Change in Acquisitions & Divestments was $265196.0 for Q4 2025 at Cryo Cell International, down from $1.7 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.7 million in Q3 2025 to a low of $12803.0 in Q3 2022.
  • A 4-year average of $418794.9 and a median of $228298.0 in 2023 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: plummeted 85.07% in 2023, then skyrocketed 1098.88% in 2024.
  • Cryo Cell International's Change in Acquisitions & Divestments stood at $20560.0 in 2022, then skyrocketed by 85.21% to $38079.0 in 2023, then surged by 313.95% to $157627.0 in 2024, then soared by 68.24% to $265196.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Change in Acquisitions & Divestments are $265196.0 (Q4 2025), $1.7 million (Q3 2025), and $419246.0 (Q2 2025).